Julia G. Butchko, Chief Development Officer at Immunovant, Inc. (IMVT), sold 6,494 shares at $29.65 ($193K) on 2024-05-22, disclosed to the SEC on 2024-05-24.
Open-market sale of $193k IMVT by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.65 | 3,247 | $96K | 50.0% |
| 2 | $29.65 | 3,247 | $96K | 50.0% |
| Total | $29.65 avg | 6,494 | $193K | 100% |
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |
| IMVT | SELL | 2024-04-10 | $33K | — | Filing → |